[18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models

by Tegnebratt, Tetyana, Lu, Li, Lee, Lucy, Meresse, Valerie, Tessier, Jean, Ishii, Nobuya, Harada, Naoki, Pisa, Pavel, Stone-Elander, Sharon
Published 2013

Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ

by Samén, Erik, Lu, Li, Mulder, Jan, Thorell, Jan-Olov, Damberg, Peter, Tegnebratt, Tetyana, Holmgren, Lars, Rundqvist, Helene, Stone-Elander, Sharon
Published 2014

Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer

by T. Tegnebratt, L. Lu, S. Eksborg, A. Chireh, P. Damberg, S. Nikkhou-Aski, T. Foukakis, H. Rundqvist, S. Holmin, R. V. Kuiper, E. Samen
Published 2018-04-01

Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells

by Buentke, E, Nordström, A, Lin, H, Björklund, A-C, Laane, E, Harada, M, Lu, L, Tegnebratt, T, Stone-Elander, S, Heyman, M, Söderhäll, S, Porwit, A, Östenson, C-G, Shoshan, M, Tamm, K Pokrovskaja, Grandér, D
Published 2011

Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [18F] FDG-PET imaging combined with proteomic approaches

by Tegnebratt, Tetyana, Ruge, Elisabeth, Bader, Sabine, Ishii, Nobuya, Aida, Satoshi, Yoshimura, Yasushi, Ooi, Chia-Huey, Lu, Li, Mitsios, Nicholas, Meresse, Valerie, Mulder, Jan, Pawlak, Michael, Venturi, Miro, Tessier, Jean, Stone-Elander, Sharon
Published 2014

Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake

by Cheng, Qing, Wållberg, Helena, Grafström, Jonas, Lu, Li, Thorell, Jan-Olov, Hägg Olofsson, Maria, Linder, Stig, Johansson, Katarina, Tegnebratt, Tetyana, Arnér, Elias S. J., Stone-Elander, Sharon, Ahlzén, Hanna-Stina Martinsson, Ståhl, Stefan
Published 2016